These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1585675)

  • 21. Whither the ANA?
    Lerner EA; Lerner MR
    Arch Dermatol; 1987 Mar; 123(3):358-62. PubMed ID: 2434034
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunofluorescence diagnosis of internal diseases (author's transl)].
    Ludwig H; Knapp W
    Wien Klin Wochenschr; 1974 Dec; 86(23):709-16. PubMed ID: 4613020
    [No Abstract]   [Full Text] [Related]  

  • 23. Determination of antibodies to nuclear antigens with special reference to dsDNA using indirect immunoperoxidase.
    Rus HG; Niculescu F; Cristea A; Malide D; Răhăian R; Climescu M; Petcovici M; Ionescu-Dorohoi T
    Arch Roum Pathol Exp Microbiol; 1987; 46(2):159-65. PubMed ID: 3332071
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-cardiolipin antibodies: a method of their detection and clinical significance].
    Nasonov EL; Alekberova ZS; Aleksandrova LZ; Prudnikova LZ; Kudriashova VF
    Klin Med (Mosk); 1987 Nov; 65(11):100-5. PubMed ID: 3323655
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody pattern and other criteria for diagnosis and classification in PSS.
    Burgos-Vargas R; Martínez-Cordero E; Reyes-López PA; Herrera-Esparza R
    J Rheumatol; 1988 Jan; 15(1):153-4. PubMed ID: 3258382
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular biology of nuclear autoantigens.
    Tan EM
    Adv Nephrol Necker Hosp; 1993; 22():213-36. PubMed ID: 7678951
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Specificity of antibodies against native DNA using Crithidia luciliae. Clinical and analytical features of patients with and without antibodies against native DNA in systemic lupus erythematosus].
    Peña Sagredo JL; Riestra Noriega JL; Sánchez Andrada S; Luceño Vázquez A; Rodríguez Valverde V
    Med Clin (Barc); 1984 Jun; 83(3):94-6. PubMed ID: 6384685
    [No Abstract]   [Full Text] [Related]  

  • 29. HEp2 ANA EIA: a new fully automated assay for the screening of antinuclear antibodies.
    Lehmann HP; Fühling I; Ott C; Hüdepohl B; Haass M
    Isr Med Assoc J; 2000 Aug; 2(8):646-8. PubMed ID: 10979370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
    Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
    Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interdisciplinary Forum on Autoimmune Disease Research: guidelines].
    Sinico RA;
    G Ital Nefrol; 2002; 19(2):212-24. PubMed ID: 14518478
    [No Abstract]   [Full Text] [Related]  

  • 34. [Methods for determining antinuclear antibodies and their clinical significance].
    Aeschlimann A; Meyer O; Kahn MF; Müller W
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1701-12. PubMed ID: 2694362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios.
    Bossuyt X; Claessens J; Belmondo T; De Langhe E; Westhovens R; Poesen K; Hüe S; Blockmans D; Fritzler MJ; Mahler M; Fierz W
    Autoimmun Rev; 2019 Nov; 18(11):102386. PubMed ID: 31520795
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antinuclear antibodies detected in autoimmune diseases].
    Asakawa H; Yamaguchi K; Tooi H
    Rinsho Byori; 1993 Aug; 41(8):897-903. PubMed ID: 8371505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antinuclear antibodies: what dermatologists need to know].
    Guillaud C; Hüe S; Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2013 Dec; 140(12):821-6. PubMed ID: 24315232
    [No Abstract]   [Full Text] [Related]  

  • 38. [A study on autoantibodies including anti-nDNA, anti-RNP and anti-Sm antibody in various autoimmune diseases].
    Kumagai T; Kameko M; Kanai M; Maruyama K
    Rinsho Byori; 1985 Mar; 33(3):293-7. PubMed ID: 3874299
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical evaluation of quantitative measurement of various antinuclear antibodies by enzyme immunoassay].
    Miyawaki S
    Rinsho Byori; 1994 May; 42(5):467-75. PubMed ID: 8022075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of rheumatologic diseases. Significance of autoantibodies against nuclear antigens].
    Poralla T; Mayet W; Hermann E; Manns M; Meyer zum Büschenfelde KH
    Fortschr Med; 1988 Dec; 106(36):726-9. PubMed ID: 3069672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.